NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve the prevention and management of migraine. After hearing and assimilating this program, the clinician will be better able to:
1. Distinguish among types of calcitonin gene-related peptide monoclonal antibodies.
2. Determine which pharmacologic agents are most appropriate for managing acute migraine, other types of migraine, and episodic cluster headaches.
3. Identify small-molecule agents that target and inhibit calcitonin gene-related peptide (CGRP) receptors for treatment of acute migraine attacks.
4. Recommend agents that manage migraine headache attacks through interactions with other serotonergic receptors, such as those that target the 5-HT7 receptors.
5. Characterize emerging therapies for the prevention and management of migraine headaches.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Ophthalmology
- Start Date: 2022-11-11 06:00:00
- End Date: 2022-11-11 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABO - 2.0 Point; Credit Type(s): Lifelong Learning (ABO)
ABO - 2.0 Point; Credit Type(s): Self-Assessment (ABO) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Neuro-Ophthalmology and Orbit